A prospective trial of midwest breast cancer patients: a p53 gene mutation is the most important predictor of adverse outcome.

Source:http://linkedlifedata.com/resource/pubmed/id/10719728

Int. J. Cancer 2000 Jan 20 89 1 32-8

Download in:

View as

Triples

General Info

PMID
10719728